Product Description: NH2-PEG3-VC-PAB-MMAE is a drug-linker conjugate for ADC, consisting of a cleavable ADC linker (NH2-PEG3-VC-PAB) and a potent tubulin inhibitor Monomethyl auristatin E (MMAE) (HY-15162). NH2-PEG3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs)[1].
Applications: Cancer-programmed cell death
Formula: C66H109N11O16
References: [1]Xiwu Hui, et al. An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index. Onco Targets Ther. 2022 Apr 8:15:331-343.
CAS Number: 2641442-97-7
Molecular Weight: 1312.64
Compound Purity: 99.10
Research Area: Cancer
Solubility: DMSO : 90 mg/mL (ultrasonic)
Target: Drug-Linker Conjugates for ADC;Microtubule/Tubulin